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TEETH DISCOLORATION AND ENAMEL HYPOPLASIA CAUSED BY ERYTHROMYCIN
J. AD '0, M.B., B.O-J., DIP. O. & G. (RAND), Obstetrician and Gynaecologist, Johannesburg; Department of Obsletrics and
Gynaecology, Universily of the Witwatersrand
The ingestion of tetracycline, be it by the mother during the
antenatal period, or by the infant in the immediate post- and
neonatal periods, may produce pigmentation and enamel hypo-
plasia in the primary and secondary dentitions of the child.'"
According to Wallman and Hilton' tetracycline may now be
the commonest cause of enamel hypoplasia in young children.
They suggest that oxytetracycline does not produce the same
effect as tetracycline, but did not have any information regard-
ing chlortetracycline or demethylchlortetracycline. The greater
the total dose of tetracycline/kg. of the birthweight, the
greater was the change.
There seems to be no reason to expect that the permanent
teeth will be affected by tetracycline given in the neonatal
period, but pigmentation might follow if the drug is given
between 2 months and 2 years of age, when the permanent
teeth are being calcified.'
Mason' raises the question of discoloration of the teeth
following administration of tetracycline on a long-term basis
for various conditions, particularly cystic fibrosis in children.
The author points out the obvious cosmetic disadvantages
which may ensue and also suggests that it is unjustified to
regard the incorporation of foreign material into the growing
skeleton as innocuous.
Swallow' reports a case of a I-year-old girl who developed
a yellow discoloration of her teeth. Her mother had been
diagnosed as having suffered from myeloblastic-monocytic
leukaemia in the fourth month of pregnancy. In addition to
cytotoxic drugs (6-mercaptopurine), she also received blood
transfusions and 5 G of tetracycline daily. The administration
of tetracycline was replaced after 17 weeks by 1 mg. of
erythromycin daily and novobiocin, 1 G daily.
The present report is that of a 20-month-old male child
who has discoloration and enamel hypoplasia of most of his
primary dentition (Fig. 1).
Fig. I. Discoloration and enamel hypoplasia of primary dentition in
a 20·month-old child.
At the 4th month of gestation the mother developed a
clinical and pathological condition diagnosed as idiopathic
nephrosis. The treatment consisted of complete bed rest and
salt-free diet. In addition she was given 750 mg. of erythromy-
cin daily throughout the rest of her pregnancy. 500 mg. of
chlorothiazide was taken 3 - 4 times weekly together with
Kalisol (500 mg. of potassium bicarbonate and 300 mg. of
potassium acid tartrate).
The infant was born normally at 37 weeks, weighing 5 lb.
13 oz. He was not breast fed, and did not suffer any neonatal
jaundice. He did not receive any medication after birth or in
the neonatal period.
DISCUSSION
Apart from neonatal jaundice, there must be few conditions,
if any, which cause such staining of the teeth in infants, and
dietary insufficiency is now rare as a cause of defective
enamel.
The fact that members of the tetracycline group of drugs
are laid down in the skeletons of animals has been known for
some years.' No serious deleterious effects have so far been
reported.
Wallman and Hilton' were fortunate in obtaining extracted
teeth and they were able to prove that the tetracycline molecule
was present in these teeth. It has not been possible to do this
study with the present case, but in the absence of any other
known cause for pigmentation and hypo-enamel formation, it
is assumed that erythromycin is the causative factor.
The management of patients requiring tetracycline groups
therefore present a problem. This, however, has been well
summarized;' 'In making a decision as to whether to use
tetracycline for long-term administration, the therapeutic
value of the drug is obviously relevant, particularly in relation
to whether equally valuable alternative medicaments are avail-
able. For many conditions there is no satisfactory alternative
to tetracyclines, and it may be worth while to accept a possi-
bility of discoloration of the teeth, or whatever theoretical
disadvantages which may be postulated from the deposition in
the bones, for the value of the unquestionable benefits of the
treatment.'
SUMMARY
I. The case of discoloration and hypoplasia of the enamel
in primary dentition in a 20-month-old male child is reported.
2. The literature is reviewed.
3. There has been no previous report of discoloration and
hypo-enamel of teeth being a complication of erythromycin
administration during pregnancy. This however must be as-
sumed as being possible, and due regard be paid to its danger.
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